Simvastatin inhibits apoptosis of endothelial cells induced by sepsis through upregulating the expression of Bcl-2 and downregulating Bax

Journal Title: World Journal of Emergency Medicine - Year 2014, Vol 5, Issue 4

Abstract

BACKGROUND: Many studies have showed that apoptosis of endothelial cells plays a curial role in the progress of sepsis. But the role of simvastatin in apoptosis of endothelial cells induced by sepsis is not clear. The present study aimed to investigate the role of simvastatin in apoptosis of endothelial cells induced by sepsis and its mechanism. METHODS: Human umbilical vein endothelial cells (HUVECs) were randomly divided into three groups: control group, sepsis serum intervention group (sepsis group) and simvastatin+sepsis serum intervention group (simvastatin group). After 24-hour incubation with corresponding culture medium, the relative growth rate of HUVECS in different groups was detected by MTT assay; the apoptosis of HUVECs was detected by Hoechst33258 assay and flow cytometry; and the expression of the Bcl-2 and Bax genes of HUVECs was detected by PCR. RESULTS: Compared with the sepsis group, HUVECs in the simvastatin group had a higher relative growth rate. Apoptotic HUVECs decreased significantly in the simvastatin group in comparison with the sepsis group. Expression of the Bcl-2 gene in HUVECs decreased obviously, but the expression of the Bax gene increased obviously after 24-hour incubation with sepsis serum; however, the expression of the Bcl-2 and Bax genes was just the opposite in the simvastatin group. CONCLUSIONS: Our study suggests that simvastatin can inhibit apoptosis of endothelial cells induced by sepsis through upregulating the expression of Bcl-2 and downregulating Bax. It may be one of the mechanisms for simvastatin to treat sepsis.

Authors and Affiliations

Keywords

Related Articles

Prehospital difficult airway management: old things still work

Airway management is a crucial skill for emergency physician, who's often called to deal with difficult airways and requests for quick, simple and effective responses, as the many factors responsible for difficulties mig...

An attending physician float shift for the improvement of physician productivity in a crowded emergency department

BACKGROUND: Patients backlogged in the emergency department (ED) waiting for an inpatient bed (boarders) continue to require the attention of ED physicians, exacerbating crowding in the ED. To address this problem, we ad...

Maternal and fetal outcomes in term premature rupture of membrane

BACKGROUND: Premature rupture of membrane (PROM) is linked to significant maternal prenatal mortalities and morbidity. In Ethiopia, where maternal mortality is still high, the maternal and fetal outcomes in PROM is very...

A new inflammation marker of chronic obstructive pulmonary disease– adiponectin

BACKGROUND: This study was undertaken to measure the concentration of adiponectin (APN) in serum and induced sputum in patients with chronic obstructive pulmonary disease (COPD during acute exacerbation (AECOPD) and at s...

May headache be the first sign of mutation in the MTHFR gene?

BACKGROUND: Cerebral venous thrombosis (CVT) is a rare disease and it has different etiologies. Inherited or acquired prothrombotic state plays a key role in the development of CVT. METHODS: A 28-year-old man who present...

Download PDF file
  • EP ID EP470666
  • DOI -
  • Views 39
  • Downloads 0

How To Cite

(2014). Simvastatin inhibits apoptosis of endothelial cells induced by sepsis through upregulating the expression of Bcl-2 and downregulating Bax. World Journal of Emergency Medicine, 5(4), 291-297. https://europub.co.uk./articles/-A-470666